Abstract
Disseminated candidiasis and other invasive fungal infections are a substantial cause of morbidity and mortality in immunocompromised and critically ill patients. Diagnosis of disseminated candidiasis via blood culture and skin biopsy can be unreliable and may delay treatment. (1,3)-β-D-glucan (BDG) assay is a rapid, cost-effective, noninvasive diagnostic screening tool for the dermatology hospitalist to consider.
Original language | English (US) |
---|---|
Pages (from-to) | 33-34+36 |
Journal | Cutis |
Volume | 106 |
Issue number | 1 |
DOIs | |
State | Published - Jul 2020 |
Externally published | Yes |
ASJC Scopus subject areas
- Medicine(all)